Risk-weighted apoB: A Superior Predictor of Coronary Heart Disease Risk Beyond Traditional Lipid Measures

Highlight

• Risk-weighted apoB (RW-apoB) is a novel lipid metric that integrates weighted contributions of LDL, triglyceride-rich lipoproteins (TRL/remnants), and lipoprotein(a) [Lp(a)] to better predict coronary heart disease (CHD) risk.
• RW-apoB reclassifies individual CHD risk significantly compared to apoB alone, identifying high-risk individuals who would otherwise be misclassified by traditional apoB measurements.
• RW-apoB consistently outperforms apoB and other traditional lipid biomarkers in risk prediction across multiple large population cohorts, including statin-treated subjects, reflecting its potential for guiding clinical decision-making.

Study Background